Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity Partners, a multi-family asset management firm based in Chicago, for consideration of up to $60 million in cash, consisting of an upfront payment of $45 million, and up to $15 million payable in the future upon the achievement of certain milestones. “This tran ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Owens & Minor has struck a deal to sell a unit that provides products and services to healthcare providers, the company said Tuesday.  Platinum Equity is paying $375 million for the business. The Owens & Minor unit will join healthcare companies including ASP Global, LifeScan and NDC in the investment firm’s portfolio.  The sale, which is scheduled to ...

Core Insights - Occidental Petroleum is positioned to enhance investments in its core oil and gas business following the divestment of its chemicals unit [1] - The company anticipates replacing the cash flow lost from the chemicals division in approximately two and a half years [1]

AdvisorsThe Company engaged Moelis & Company LLC as financial advisor to assist with the processes to sell the Company's Latin American businesses. About Clear Channel Outdoor Holdings, Inc.Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is at the forefront of driving innovation in the out-of-home advertising industry. Our dynamic advertising platform is broadening the pool of advertisers using its medium through the expansion of digital billboards and displays and the integration of data analytics and pr ...

Core Insights - BioCryst Pharmaceuticals has completed the sale of its European ORLADEYO business to Neopharmed Gentili for $250 million, with potential future milestones of up to $14 million [1][8] - The transaction allows BioCryst to focus on its core U.S. market, significantly improving its operating margin and cash flow generation [2][8] - Neopharmed Gentili will manage the commercialization of ORLADEYO in Europe, retaining the existing European commercial organization built by BioCryst [8] Transaction Details - The sale price of $250 million reflects a multiple of approximately 5.4 times sales over the last twelve months ending June 2025 [8] - BioCryst intends to use the proceeds to retire a $199 million Pharmakon term loan, resulting in a cleaner balance sheet for future strategic activities [8] Strategic Advantages - The divestiture of the European business, which was approximately breakeven on a direct basis, provides an immediate improvement to BioCryst's operating margin [8] - The transaction enhances BioCryst's strategic optionality and positions the company to reach the upper half of its 2025 revenue guidance range of $580 million to $600 million, even without European revenue [2][8]

Core Viewpoint - German automotive and industrial supplier Norma is selling its water management business to U.S. rival Advanced Drainage Systems for $1 billion, which will significantly impact its revenue and strategic focus [1][2]. Group 1: Deal Details - The sale is valued at $1 billion and is expected to close in the first quarter of 2026 [1][3]. - Norma anticipates a net cash inflow of approximately 620 million to 640 million euros ($731 million to $755 million) from the transaction [2][3]. - The company plans to allocate 300 million euros of the proceeds to repay debt and reserve up to 70 million euros for potential acquisitions in the industrial applications sector [3]. Group 2: Financial Impact - Following the announcement, shares in Norma initially rose by 4% but later fell by 3.8% [2]. - The company expects to lose about 25% of its forecast revenue for the year due to the sale, revising its full-year sales guidance to a range of 810 million to 830 million euros, down from a previous estimate of 1.1 billion to 1.2 billion euros [4]. - The adjusted EBIT margin forecast from continuing operations has been lowered to no more than around 1%, down from a previous forecast of 6%-8% [5]. Group 3: Strategic Focus - The management board intends to return the remaining portion of the net cash inflow to shareholders, potentially through a share buyback program [3]. - The water management business, which generated 90% of its revenue from the U.S. agricultural sector, will be removed from financial reporting starting in October [2][4].

Group 1 - BGSF Inc. announced a special cash dividend of $2.00 per share, payable on September 30 to shareholders of record as of September 23, following the sale of its Professional Division [1][2] - The company completed the $99 million sale of its Professional Division to INSPYR Solutions, with proceeds primarily aimed at paying down debt and funding investments in its property management business [2][3] - Interim Co-CEOs emphasized that the dividend is a prudent step to enhance shareholder value while ensuring liquidity for future opportunities [1][3] Group 2 - BGSF plans to geographically expand and strengthen its specialized property management services to maintain financial stability [3] - The divestiture allows the company to focus on its core strengths and create long-term value [3] - BGSF shares increased by 14.37% to $7.320 following the announcement [4]

Core Viewpoint - Terex Corporation (TEX) has entered into a definitive agreement to sell its Terex Tower and Rough Terrain Cranes businesses to Raimondi Cranes SpA, aligning with its strategy to reduce cyclicality and enhance core business growth [1][7]. Group 1: Details of the Deal - The transaction includes the sale of Terex's Italian facilities, specifically the Terex Tower Cranes facility in Fontanafredda and the Terex Rough Terrain Cranes facility in Crespellano, along with the Terex North America Cranes service and support operation in Wilmington, NC [2][3]. - Franna pick and carry cranes are excluded from the agreement, and Terex will continue their production at its facilities in Eagle Farm, Brisbane, and Hosur, India [2]. Group 2: Strategic Implications - The deal is expected to create synergies for Raimondi Cranes by integrating Terex's Tower and Rough Terrain cranes, thereby expanding their range of solutions [3]. - Terex aims to align its production and cost structure across its segments in response to customer demand, while managing costs and working capital effectively [4]. Group 3: Financial Performance - In Q2 2025, Terex reported adjusted earnings of $1.49 per share, a 31% decline year-over-year, but above the Zacks Consensus Estimate of $1.44 [5]. - Revenues for the quarter reached $1.487 billion, reflecting a 7.6% increase from the previous year and surpassing the Zacks Consensus Estimate of $1.455 billion [5]. - Terex projects revenues between $5.3 billion and $5.5 billion for 2025, with earnings per share expected to be between $4.70 and $5.10 [5]. Group 4: Stock Performance - Over the past year, Terex's shares have decreased by 2.5%, contrasting with a 24.7% decline in the industry [6].

Core Viewpoint - Terex Corporation has signed a definitive agreement to sell its Tower and Rough Terrain Cranes businesses to Raimondi Cranes SpA, with the transaction expected to close in the second half of 2025, pending regulatory approvals [1][2]. Group 1: Terex Corporation - The sale includes the Terex Tower Cranes facility in Fontanafredda, Italy, the Terex Rough Terrain Cranes facility in Crespellano, Italy, and the Terex North America Cranes service operation in Wilmington, North Carolina [1]. - This divestiture aligns with Terex's strategic focus to reduce cyclicality while accelerating growth and leveraging synergies across its three business segments: Materials Processing, Aerials, and Environmental Solutions [2]. - Terex will continue to manufacture Franna pick and carry cranes at its Eagle Farm facility in Brisbane, Australia, and the Terex Hosur facility in India [2]. Group 2: Raimondi Cranes - Raimondi Cranes, based in Milan, Italy, is recognized for its product innovation and customer service, and aims to enhance its capabilities through this acquisition [2]. - The acquisition is seen as a milestone for Raimondi in its journey to become a global lifting conglomerate, creating synergies that will support sustainable growth [2][5]. - Founded in 1863, Raimondi has delivered over 17,000 cranes globally and continues to focus on quality, innovation, and customer satisfaction in the heavy lifting sector [4][5].

Core Viewpoint - Iveco Group has signed a definitive agreement to sell its Defence Business to Leonardo S.p.A. for an enterprise value of €1.7 billion, creating a European champion in the land defence segment [1][2]. Group 1: Transaction Details - The transaction is expected to be completed by 31 March 2026, pending regulatory approvals and carve-out completion [3]. - Upon completion, Iveco Group plans to distribute the net proceeds to shareholders through an extraordinary dividend [3]. Group 2: Strategic Implications - The sale allows both the Defence Business and commercial vehicles business to focus more strategically, enhancing their competitive capabilities [2]. - The partnership will combine mobility solutions and protected platforms from Iveco's Defence Business with Leonardo's advanced systems, delivering comprehensive land defence capabilities [2]. Group 3: Financial Performance - The Defence Business, comprising Iveco Defence Vehicles (IDV) and ASTRA, generated revenues of €1.1 billion in 2024 [5].